Ten directions for improving clinical therapeutic effect of pancreatic cancer in the future.
10.3760/cma.j.cn112139-20211109-00525
- VernacularTitle:未来提高胰腺癌临床诊治效果的十大方向
- Author:
Liang LIU
1
;
Wen Quan WANG
1
;
Wen Hui LOU
1
Author Information
1. Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Pancreatic Neoplasms/therapy*;
Treatment Outcome
- From:
Chinese Journal of Surgery
2022;60(1):10-16
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cancer is one of the most malignant digestive system tumors. In the recent decade, the effect of diagnosis and treatment of pancreatic cancer has improved due to the renewal of treatment concept and the popularization of effective treatment. However, the overall efficacy of pancreatic cancer is still dismal and the 5-year survival rate is only about 10%. Further improving the diagnosis and treatment of pancreatic cancer is the top priority of oncology research and clinical practice. Based on past clinical and scientific research experience, the authors have proposed ten hot spots and future directions for a reference, which focusing on early prevention, early diagnosis, and early treatment of pancreatic cancer, molecular typing and precise treatment, new drug development and regimen combination, surgical technology and strategy change, model establishment and database development, as well as innovation of traditional Chinese medicine and breakthrough of treatment concept. A breakthrough in the diagnosis and treatment of pancreatic cancer in the next ten years is raising hope, when doctors can truly prevent and control pancreatic cancer.
